aluates Reports

$ 0.0

Automative

Global Acute Agitation and Aggression Therapeutics Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-16E13673

Global Acute Agitation and Aggression Therapeutics Market Research Report 2023

BUY CHAPTERS

Global Acute Agitation and Aggression Therapeutics Market Research Report 2025

Code: QYRE-Auto-16E13673

Report

July 2025

Pages:77

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Eli Lilly and Company

Pfizer Inc

Ono Pharmaceutical

Otsuka Holdings

GlaxoSmithKline PLC

Bristol–Myers Squibb

Johnson & Johnson

H Lundbeck A S

Acute Agitation and Aggression Therapeutics Market Size

The global market for Acute Agitation and Aggression Therapeutics was valued at US$ 2385 million in the year 2024 and is projected to reach a revised size of US$ 3566 million by 2031, growing at a CAGR of 6.0% during the forecast period.

Acute Agitation and Aggression Therapeutics Market

With acute agitation and aggression being a common symptom among patients suffering from various types of mental illnesses, the healthcare industry is expending efforts towards developing effective panaceas.

North American market for Acute Agitation and Aggression Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Acute Agitation and Aggression Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Acute Agitation and Aggression Therapeutics in Hospitals & Ambulatory Surgical Centers is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Acute Agitation and Aggression Therapeutics include Eli Lilly and Company, Pfizer, Ono Pharmaceutical, Otsuka Holdings, GlaxoSmithKline, Bristol-Myers Squibb, Johnson & Johnson, H. Lundbeck A/S, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Acute Agitation and Aggression Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Agitation and Aggression Therapeutics.

The Acute Agitation and Aggression Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Acute Agitation and Aggression Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Acute Agitation and Aggression Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Acute Agitation and Aggression Therapeutics Market Report

Report Metric	Details
Report Name	Acute Agitation and Aggression Therapeutics Market
Accounted market size in year	US$ 2385 million
Forecasted market size in 2031	US$ 3566 million
CAGR	6.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Oral Intramuscular Injection Others
Segment by Application	Hospitals & Ambulatory Surgical Centers Psychiatric Care Facilities Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Eli Lilly and Company, Pfizer, Ono Pharmaceutical, Otsuka Holdings, GlaxoSmithKline, Bristol-Myers Squibb, Johnson & Johnson, H. Lundbeck A/S
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Acute Agitation and Aggression Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Acute Agitation and Aggression Therapeutics Market growing?

Ans: The Acute Agitation and Aggression Therapeutics Market witnessing a CAGR of 6.0% during the forecast period 2025-2031.

What is the Acute Agitation and Aggression Therapeutics Market size in 2031?

Ans: The Acute Agitation and Aggression Therapeutics Market size in 2031 will be US$ 3566 million.

Who are the main players in the Acute Agitation and Aggression Therapeutics Market report?

Ans: The main players in the Acute Agitation and Aggression Therapeutics Market are Eli Lilly and Company, Pfizer, Ono Pharmaceutical, Otsuka Holdings, GlaxoSmithKline, Bristol-Myers Squibb, Johnson & Johnson, H. Lundbeck A/S

What are the Application segmentation covered in the Acute Agitation and Aggression Therapeutics Market report?

Ans: The Applications covered in the Acute Agitation and Aggression Therapeutics Market report are Hospitals & Ambulatory Surgical Centers, Psychiatric Care Facilities, Others

What are the Type segmentation covered in the Acute Agitation and Aggression Therapeutics Market report?

Ans: The Types covered in the Acute Agitation and Aggression Therapeutics Market report are Oral, Intramuscular Injection, Others

Recommended Reports

Mental Health Therapeutics

Acute Disease Treatments

Neurological Drug Markets

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Acute Agitation and Aggression Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Oral

1.2.3 Intramuscular Injection

1.2.4 Others

1.3 Market by Application

1.3.1 Global Acute Agitation and Aggression Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals & Ambulatory Surgical Centers

1.3.3 Psychiatric Care Facilities

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Acute Agitation and Aggression Therapeutics Market Perspective (2020-2031)

2.2 Global Acute Agitation and Aggression Therapeutics Growth Trends by Region

2.2.1 Global Acute Agitation and Aggression Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Acute Agitation and Aggression Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Acute Agitation and Aggression Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Acute Agitation and Aggression Therapeutics Market Dynamics

2.3.1 Acute Agitation and Aggression Therapeutics Industry Trends

2.3.2 Acute Agitation and Aggression Therapeutics Market Drivers

2.3.3 Acute Agitation and Aggression Therapeutics Market Challenges

2.3.4 Acute Agitation and Aggression Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Acute Agitation and Aggression Therapeutics Players by Revenue

3.1.1 Global Top Acute Agitation and Aggression Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Acute Agitation and Aggression Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Acute Agitation and Aggression Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Acute Agitation and Aggression Therapeutics Revenue

3.4 Global Acute Agitation and Aggression Therapeutics Market Concentration Ratio

3.4.1 Global Acute Agitation and Aggression Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Acute Agitation and Aggression Therapeutics Revenue in 2024

3.5 Global Key Players of Acute Agitation and Aggression Therapeutics Head office and Area Served

3.6 Global Key Players of Acute Agitation and Aggression Therapeutics, Product and Application

3.7 Global Key Players of Acute Agitation and Aggression Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Acute Agitation and Aggression Therapeutics Breakdown Data by Type

4.1 Global Acute Agitation and Aggression Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Acute Agitation and Aggression Therapeutics Forecasted Market Size by Type (2026-2031)

5 Acute Agitation and Aggression Therapeutics Breakdown Data by Application

5.1 Global Acute Agitation and Aggression Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Acute Agitation and Aggression Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Acute Agitation and Aggression Therapeutics Market Size (2020-2031)

6.2 North America Acute Agitation and Aggression Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Acute Agitation and Aggression Therapeutics Market Size by Country (2020-2025)

6.4 North America Acute Agitation and Aggression Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Acute Agitation and Aggression Therapeutics Market Size (2020-2031)

7.2 Europe Acute Agitation and Aggression Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Acute Agitation and Aggression Therapeutics Market Size by Country (2020-2025)

7.4 Europe Acute Agitation and Aggression Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Acute Agitation and Aggression Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Acute Agitation and Aggression Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Acute Agitation and Aggression Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Acute Agitation and Aggression Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Acute Agitation and Aggression Therapeutics Market Size (2020-2031)

9.2 Latin America Acute Agitation and Aggression Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Acute Agitation and Aggression Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Acute Agitation and Aggression Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Acute Agitation and Aggression Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Acute Agitation and Aggression Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Acute Agitation and Aggression Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Acute Agitation and Aggression Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Eli Lilly and Company

11.1.1 Eli Lilly and Company Company Details

11.1.2 Eli Lilly and Company Business Overview

11.1.3 Eli Lilly and Company Acute Agitation and Aggression Therapeutics Introduction

11.1.4 Eli Lilly and Company Revenue in Acute Agitation and Aggression Therapeutics Business (2020-2025)

11.1.5 Eli Lilly and Company Recent Development

11.2 Pfizer

11.2.1 Pfizer Company Details

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Acute Agitation and Aggression Therapeutics Introduction

11.2.4 Pfizer Revenue in Acute Agitation and Aggression Therapeutics Business (2020-2025)

11.2.5 Pfizer Recent Development

11.3 Ono Pharmaceutical

11.3.1 Ono Pharmaceutical Company Details

11.3.2 Ono Pharmaceutical Business Overview

11.3.3 Ono Pharmaceutical Acute Agitation and Aggression Therapeutics Introduction

11.3.4 Ono Pharmaceutical Revenue in Acute Agitation and Aggression Therapeutics Business (2020-2025)

11.3.5 Ono Pharmaceutical Recent Development

11.4 Otsuka Holdings

11.4.1 Otsuka Holdings Company Details

11.4.2 Otsuka Holdings Business Overview

11.4.3 Otsuka Holdings Acute Agitation and Aggression Therapeutics Introduction

11.4.4 Otsuka Holdings Revenue in Acute Agitation and Aggression Therapeutics Business (2020-2025)

11.4.5 Otsuka Holdings Recent Development

11.5 GlaxoSmithKline

11.5.1 GlaxoSmithKline Company Details

11.5.2 GlaxoSmithKline Business Overview

11.5.3 GlaxoSmithKline Acute Agitation and Aggression Therapeutics Introduction

11.5.4 GlaxoSmithKline Revenue in Acute Agitation and Aggression Therapeutics Business (2020-2025)

11.5.5 GlaxoSmithKline Recent Development

11.6 Bristol-Myers Squibb

11.6.1 Bristol-Myers Squibb Company Details

11.6.2 Bristol-Myers Squibb Business Overview

11.6.3 Bristol-Myers Squibb Acute Agitation and Aggression Therapeutics Introduction

11.6.4 Bristol-Myers Squibb Revenue in Acute Agitation and Aggression Therapeutics Business (2020-2025)

11.6.5 Bristol-Myers Squibb Recent Development

11.7 Johnson & Johnson

11.7.1 Johnson & Johnson Company Details

11.7.2 Johnson & Johnson Business Overview

11.7.3 Johnson & Johnson Acute Agitation and Aggression Therapeutics Introduction

11.7.4 Johnson & Johnson Revenue in Acute Agitation and Aggression Therapeutics Business (2020-2025)

11.7.5 Johnson & Johnson Recent Development

11.8 H. Lundbeck A/S

11.8.1 H. Lundbeck A/S Company Details

11.8.2 H. Lundbeck A/S Business Overview

11.8.3 H. Lundbeck A/S Acute Agitation and Aggression Therapeutics Introduction

11.8.4 H. Lundbeck A/S Revenue in Acute Agitation and Aggression Therapeutics Business (2020-2025)

11.8.5 H. Lundbeck A/S Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Eli Lilly and Company

Pfizer Inc

Ono Pharmaceutical

Otsuka Holdings

GlaxoSmithKline PLC

Bristol–Myers Squibb

Johnson & Johnson

H Lundbeck A S

List of Tables

Table 1. Global Acute Agitation and Aggression Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Oral

Table 3. Key Players of Intramuscular Injection

Table 4. Key Players of Others

Table 5. Global Acute Agitation and Aggression Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Acute Agitation and Aggression Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Acute Agitation and Aggression Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Acute Agitation and Aggression Therapeutics Market Share by Region (2020-2025)

Table 9. Global Acute Agitation and Aggression Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Acute Agitation and Aggression Therapeutics Market Share by Region (2026-2031)

Table 11. Acute Agitation and Aggression Therapeutics Market Trends

Table 12. Acute Agitation and Aggression Therapeutics Market Drivers

Table 13. Acute Agitation and Aggression Therapeutics Market Challenges

Table 14. Acute Agitation and Aggression Therapeutics Market Restraints

Table 15. Global Acute Agitation and Aggression Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Acute Agitation and Aggression Therapeutics Market Share by Players (2020-2025)

Table 17. Global Top Acute Agitation and Aggression Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Agitation and Aggression Therapeutics as of 2024)

Table 18. Ranking of Global Top Acute Agitation and Aggression Therapeutics Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Acute Agitation and Aggression Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Acute Agitation and Aggression Therapeutics, Headquarters and Area Served

Table 21. Global Key Players of Acute Agitation and Aggression Therapeutics, Product and Application

Table 22. Global Key Players of Acute Agitation and Aggression Therapeutics, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Acute Agitation and Aggression Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Acute Agitation and Aggression Therapeutics Revenue Market Share by Type (2020-2025)

Table 26. Global Acute Agitation and Aggression Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Acute Agitation and Aggression Therapeutics Revenue Market Share by Type (2026-2031)

Table 28. Global Acute Agitation and Aggression Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Acute Agitation and Aggression Therapeutics Revenue Market Share by Application (2020-2025)

Table 30. Global Acute Agitation and Aggression Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Acute Agitation and Aggression Therapeutics Revenue Market Share by Application (2026-2031)

Table 32. North America Acute Agitation and Aggression Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Acute Agitation and Aggression Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Acute Agitation and Aggression Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Acute Agitation and Aggression Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Acute Agitation and Aggression Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Acute Agitation and Aggression Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Acute Agitation and Aggression Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Acute Agitation and Aggression Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Acute Agitation and Aggression Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Acute Agitation and Aggression Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Acute Agitation and Aggression Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Acute Agitation and Aggression Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Acute Agitation and Aggression Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Acute Agitation and Aggression Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Acute Agitation and Aggression Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 47. Eli Lilly and Company Company Details

Table 48. Eli Lilly and Company Business Overview

Table 49. Eli Lilly and Company Acute Agitation and Aggression Therapeutics Product

Table 50. Eli Lilly and Company Revenue in Acute Agitation and Aggression Therapeutics Business (2020-2025) & (US$ Million)

Table 51. Eli Lilly and Company Recent Development

Table 52. Pfizer Company Details

Table 53. Pfizer Business Overview

Table 54. Pfizer Acute Agitation and Aggression Therapeutics Product

Table 55. Pfizer Revenue in Acute Agitation and Aggression Therapeutics Business (2020-2025) & (US$ Million)

Table 56. Pfizer Recent Development

Table 57. Ono Pharmaceutical Company Details

Table 58. Ono Pharmaceutical Business Overview

Table 59. Ono Pharmaceutical Acute Agitation and Aggression Therapeutics Product

Table 60. Ono Pharmaceutical Revenue in Acute Agitation and Aggression Therapeutics Business (2020-2025) & (US$ Million)

Table 61. Ono Pharmaceutical Recent Development

Table 62. Otsuka Holdings Company Details

Table 63. Otsuka Holdings Business Overview

Table 64. Otsuka Holdings Acute Agitation and Aggression Therapeutics Product

Table 65. Otsuka Holdings Revenue in Acute Agitation and Aggression Therapeutics Business (2020-2025) & (US$ Million)

Table 66. Otsuka Holdings Recent Development

Table 67. GlaxoSmithKline Company Details

Table 68. GlaxoSmithKline Business Overview

Table 69. GlaxoSmithKline Acute Agitation and Aggression Therapeutics Product

Table 70. GlaxoSmithKline Revenue in Acute Agitation and Aggression Therapeutics Business (2020-2025) & (US$ Million)

Table 71. GlaxoSmithKline Recent Development

Table 72. Bristol-Myers Squibb Company Details

Table 73. Bristol-Myers Squibb Business Overview

Table 74. Bristol-Myers Squibb Acute Agitation and Aggression Therapeutics Product

Table 75. Bristol-Myers Squibb Revenue in Acute Agitation and Aggression Therapeutics Business (2020-2025) & (US$ Million)

Table 76. Bristol-Myers Squibb Recent Development

Table 77. Johnson & Johnson Company Details

Table 78. Johnson & Johnson Business Overview

Table 79. Johnson & Johnson Acute Agitation and Aggression Therapeutics Product

Table 80. Johnson & Johnson Revenue in Acute Agitation and Aggression Therapeutics Business (2020-2025) & (US$ Million)

Table 81. Johnson & Johnson Recent Development

Table 82. H. Lundbeck A/S Company Details

Table 83. H. Lundbeck A/S Business Overview

Table 84. H. Lundbeck A/S Acute Agitation and Aggression Therapeutics Product

Table 85. H. Lundbeck A/S Revenue in Acute Agitation and Aggression Therapeutics Business (2020-2025) & (US$ Million)

Table 86. H. Lundbeck A/S Recent Development

Table 87. Research Programs/Design for This Report

Table 88. Key Data Information from Secondary Sources

Table 89. Key Data Information from Primary Sources

Table 90. Authors List of This Report

List of Figures

Figure 1. Acute Agitation and Aggression Therapeutics Picture

Figure 2. Global Acute Agitation and Aggression Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Acute Agitation and Aggression Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Oral Features

Figure 5. Intramuscular Injection Features

Figure 6. Others Features

Figure 7. Global Acute Agitation and Aggression Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Acute Agitation and Aggression Therapeutics Market Share by Application: 2024 VS 2031

Figure 9. Hospitals & Ambulatory Surgical Centers Case Studies

Figure 10. Psychiatric Care Facilities Case Studies

Figure 11. Others Case Studies

Figure 12. Acute Agitation and Aggression Therapeutics Report Years Considered

Figure 13. Global Acute Agitation and Aggression Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Acute Agitation and Aggression Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Acute Agitation and Aggression Therapeutics Market Share by Region: 2024 VS 2031

Figure 16. Global Acute Agitation and Aggression Therapeutics Market Share by Players in 2024

Figure 17. Global Top Acute Agitation and Aggression Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Agitation and Aggression Therapeutics as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Acute Agitation and Aggression Therapeutics Revenue in 2024

Figure 19. North America Acute Agitation and Aggression Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Acute Agitation and Aggression Therapeutics Market Share by Country (2020-2031)

Figure 21. United States Acute Agitation and Aggression Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Acute Agitation and Aggression Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Acute Agitation and Aggression Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Acute Agitation and Aggression Therapeutics Market Share by Country (2020-2031)

Figure 25. Germany Acute Agitation and Aggression Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Acute Agitation and Aggression Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Acute Agitation and Aggression Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Acute Agitation and Aggression Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Acute Agitation and Aggression Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Acute Agitation and Aggression Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Acute Agitation and Aggression Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Acute Agitation and Aggression Therapeutics Market Share by Region (2020-2031)

Figure 33. China Acute Agitation and Aggression Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Acute Agitation and Aggression Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Acute Agitation and Aggression Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Acute Agitation and Aggression Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Acute Agitation and Aggression Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Acute Agitation and Aggression Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Acute Agitation and Aggression Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Acute Agitation and Aggression Therapeutics Market Share by Country (2020-2031)

Figure 41. Mexico Acute Agitation and Aggression Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Acute Agitation and Aggression Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Acute Agitation and Aggression Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Acute Agitation and Aggression Therapeutics Market Share by Country (2020-2031)

Figure 45. Turkey Acute Agitation and Aggression Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Acute Agitation and Aggression Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Acute Agitation and Aggression Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Eli Lilly and Company Revenue Growth Rate in Acute Agitation and Aggression Therapeutics Business (2020-2025)

Figure 49. Pfizer Revenue Growth Rate in Acute Agitation and Aggression Therapeutics Business (2020-2025)

Figure 50. Ono Pharmaceutical Revenue Growth Rate in Acute Agitation and Aggression Therapeutics Business (2020-2025)

Figure 51. Otsuka Holdings Revenue Growth Rate in Acute Agitation and Aggression Therapeutics Business (2020-2025)

Figure 52. GlaxoSmithKline Revenue Growth Rate in Acute Agitation and Aggression Therapeutics Business (2020-2025)

Figure 53. Bristol-Myers Squibb Revenue Growth Rate in Acute Agitation and Aggression Therapeutics Business (2020-2025)

Figure 54. Johnson & Johnson Revenue Growth Rate in Acute Agitation and Aggression Therapeutics Business (2020-2025)

Figure 55. H. Lundbeck A/S Revenue Growth Rate in Acute Agitation and Aggression Therapeutics Business (2020-2025)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Acute Agitation and Aggression Treatment Market Insights Forecast to 2030

Global Alzherimer s Agitation Aggression Treatment Market Research Report 2025

Global Alzheimer s Agitation Clinical Treatment Market Research Report 2025

Global Alzheimer s Agitation Treatment Market Research Report 2024

Agoraphobia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Acute Kidney Injury Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anti inflammatory Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anxiety Disorders And Depression Therapeutic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global General Anxiety Disorder Therapeutics Market Research Report 2025

Drugs for Treating Mental Disorders Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anti Anxiety Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Attention Deficit Hyperactivity Disorder Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Acute Lung Injury Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Post Traumatic Stress Disorder Therapeutics Market Insights Forecast to 2030

Acute Wound Care Market

Anti Suicide Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Amnestic Disorders Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Treatment for Mental Health Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Mental Disorders Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions